ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on development products and technologies to combat various diseases. Co. develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. It has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1701, ABV-1519, and ABV-1703. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). It is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). We show 17 historical shares outstanding datapoints in our ABVC shares outstanding history coverage, used to compute ABVC market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ABVC market cap history over the course of time is important for investors
interested in comparing ABVC's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ABVC versus a peer is one thing; comparing
ABVC market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ABVC can fluctuate over the course of history.
With this page we aim to empower investors researching ABVC by allowing them to research the ABVC market cap history. |
Free ABVC Email Alerts:
Video: The Importance of Market Cap
